Pharma Journalist -

SMi announce key highlights ahead of RNA Therapeutics 2020, including topics to be discussed and confirmed attendees. In less than 6 weeks, the doors will open to SMi's RNA…
Read More...

SMi has released an exclusive interview with industry expert Shikta Das, Independent Senior Data Scientist, ahead of the upcoming Disruptive Technologies in Pharma conference this…
Read More...

Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon's Proteomics and Immunology business,…
Read More...

SMi Reports: Only 2 weeks left to register for Pre-Filled Syringes & Injectable Drug Devices 2020 Just 2 weeks remain until Europe's leading conference on Pre-Filled Syringes…
Read More...

Charles River Laboratories International announced that it has completed the previously announced acquisition of HemaCare Corporation for approximately $380 million in cash, or $25.40…
Read More...

Leap Therapeutics and BeiGene announced an exclusive option and license agreement for the clinical development and commercialization of DKN-01, Leap's anti-Dickkopf-1 (DKK1) antibody,…
Read More...

SMi reports: The countdown begins for the long anticipated 9th Annual Pharmaceutical Microbiology UK Conference in London this month. The 9th Annual Pharmaceutical Microbiology UK…
Read More...

SMi Reports: Co-chairs invite senior pharmaceutical professionals to join SMi's 3D Cell Culture Conference, taking place in February 2020 in London. SMi’s 4th annual 3D Cell Culture…
Read More...

AstraZeneca announced that it has agreed to sell the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) in a number of European, African and other countries1 to…
Read More...

PharmaMar and Jazz Pharmaceuticals plc announced that PharmaMar and Jazz Pharmaceuticals Ireland Limited have entered into an exclusive license agreement for lurbinectedin in the United…
Read More...